SNISARENKO JOHN (Chief Commercial Officer) received a stock award from OYSTER POINT PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/11/2022ACC: 0001209191-22-002980
Officer· Chief Commercial Officer
Since Oct 2019
+66.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
66.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.10K
Price / share
—
Trade value
—
% of position
66.4%
1/9/2022
18.22K→30.32K
Total
Net shares
+12.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2022 | A · Award | +12.10K | — | — | 66.4% | 18.22K | 30.32K |
| Total | +12.10K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
54.50K shares
Shares
+54.50K
Strike price
16.00
Held after
54.50K
Exercisable
—
1/9/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock54.50K shares | 1/9/2022 | A · Award | +54.50K | 16.00 | — | 54.50K |